Stock Earnings

Question 1

What are Aspire Biopharma Holdings Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Aspire Biopharma Holdings Inc has a total asset of $6, Net loss of $-12

Question 2

What are the key financial ratios for ASBP?

Accepted Answer

Aspire Biopharma Holdings Inc's Current ratio is 0.4, has a Net margin is 0, sales per share of $0.

Question 3

How is Aspire Biopharma Holdings Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Aspire Biopharma Holdings Inc data is not available.

Question 4

Is Aspire Biopharma Holdings Inc profitable?

Accepted Answer

no, according to the latest financial statements, Aspire Biopharma Holdings Inc has a net loss of $-12

Question 5

Does Aspire Biopharma Holdings Inc have any liabilities?

Accepted Answer

yes, Aspire Biopharma Holdings Inc has liability of 15

Question 6

How many outstanding shares for Aspire Biopharma Holdings Inc?

Accepted Answer

Aspire Biopharma Holdings Inc has a total outstanding shares of 7.76

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2020
Revenue	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--
Cost of Revenue	--	--	--	--	--
Gross Profit	--	--	--	--	--
Selling, General & Admin	15	3	1	0	--
Research & Development	0	--	--	--	--
Operating Expenses	16	3	1	0	--
Other Non Operating Income (Expenses)	-8	-9	--	--	--
Pretax Income	-27	-12	4	3	--
Income Tax Expense	--	--	--	--	--
Net Income	-27	-12	4	3	--
Net Income Growth	800%	-400%	33%	--	--
Shares Outstanding (Diluted)	49.33	8.24	19.17	31.68	--
Shares Change (YoY)	483%	-56.99%	-39%	--	--
EPS (Diluted)	-0.55	-1.52	0.23	0.11	--
EPS Growth	48%	-753%	112%	--	--
Free Cash Flow	-2	-2	0	-1	--
Free Cash Flow Per Share	-0.04	-0.24	0	-0.03	--
Gross Margin	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	--
Free Cash Flow Margin	0%	0%	0%	0%	--
EBITDA	--	--	--	--	--
EBITDA Margin	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--
EBIT	-16	-3	-1	0	0
EBIT Margin	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--

Aspire Biopharma Holdings Inc (ASBP) Price